Skip to main content

Q&As

ALN
March 30, 2020
Dr Sonpal addresses common questions patients are asking about COVID-19, how hospitals and practices are following sanitary measures to reduce potential exposure between patients, and the reports on gastrointestinal symptoms.
The Dermatologist
March 27, 2020
As of March 27, 2020, the United States has become the epicenter of the coronavirus pandemic. Misha Rosenbach, MD, answered several questions regarding the current pandemic.
ALN
March 26, 2020
Cases of the coronavirus pandemic will continue to increase in the United States for the foreseeable future. Many patients with autoimmune diseases or on immunosuppressant medications will wonder how this virus will impact them and their treatment. Adam Cheifetz discussed patients’ concerns and his current recommendations for those on immunosuppressant therapies.
Rheumatology Consultant
March 10, 2020
A new analysis of the ArthritisPower registry aimed to identify factors that patients believe influenced their physician’s treatment decisions. Lead authors W. Benjamin Nowell, PhD, and Kelly Gavigan, MPH, answered our questions.
Gastroenterology Consultant
March 10, 2020
Maitreyi Raman, MD, MSc, answers our questions about how the low FODMAP diet affects irritable bowel syndrome symptoms, concerns about prescribing the low FODMAP diet, and factors that need to be considered before prescribing the low FODMAP diet.
Rheumatology Consultant
March 09, 2020
Atul Deodhar, MD, MRCP, from Oregon Health and Science University, answers our questions about the findings from the DISCOVER-1 clinical trial on the efficacy of guselkumab for the treatment of patients with psoriatic arthritis.
Rheumatology Consultant
March 04, 2020
Jillian Rose, PhD, MPH, LCSW, and Priscilla Toral, LCSW, both from Hospital for Special Surgery, answer our questions about their research on self-reported needs and concerns of men with systemic lupus erythematosus.
ALN
February 26, 2020
Erik Stratman, MD, presented on cutaneous manifestations of rheumatologic diseases at the ODAC Dermatology, Aesthetics, and Surgery Conference. He shared pearls with The Dermatologist on diagnosing and treating these conditions.
Rheumatology Consultant
February 20, 2020
David Bursill, MD, answers our questions about the consensus statement from the Gout, Hyperuricemia and Crystal-Associated Disease Network on recommended nomenclature for disease states of gout.
Rheumatology Consultant
February 10, 2020
W. Benjamin Nowell, PhD, answers our questions about his research on patient beliefs and perceptions relating to methotrexate use in the management of rheumatoid arthritis and psoriatic arthritis.
Back to Top